glp-1 drugs eli lilly Oral Orforglipron Is Approved for Obesity Eli Lilly Just Launched a

It does mean the science is moving toward a broader view of GLP-1s as metabolic regulators, not just obesity drugs

As Alzheimers disease is a progressive neurodegenerative disease with no cure, finding effective preventative strategies could notably improve the quality of life for patients with diabetes, reducing the burden of both diseases on patients, families, and healthcare systems. Verna Porter, MD Xu said their next research steps will include investigating if the same is true for neurodegenerative and neurological diseases, as well as examining tirzepatide the active ingredient in Mounjaro and Zepbound which she said is a more potent GLP-1RA

Some people find that semaglutide provides less robust glucose control than tirzepatide due to the single versus dual receptor mechanism

They were randomly assigned to receive different doses of Retatrutide or a placebo over 48 weeks